Nanae Fukaya

The α-glucosidase inhibitor miglitol decreases glucose fluctuations and gene expression of inflammatory cytokines induced by hyperglycemia in peripheral leukocytes

Nanae Fukaya, Kazuki Mochizuki, Masaya Shimada et al. · Nutrition · 2009 · 39 citations

Inflammation, Metabolic Syndrome, Inflammatory Cytokines +14

The α-glucosidase inhibitor miglitol decreases glucose fluctuations and inflammatory cytokine gene expression in peripheral leukocytes of Japanese patients with type 2 diabetes mellitus

Takeshi Osonoi, Miyoko Saito, Kazuki Mochizuki et al. · Metabolism · 2010 · 31 citations

Inflammation, Metabolic Syndrome, α-Glucosidase Inhibitor Miglitol +10

The α-glucosidase inhibitor miglitol delays the development of diabetes and dysfunctional insulin secretion in pancreatic β-cells in OLETF rats

Nanae Fukaya, Kazuki Mochizuki, Yutaro Tanaka et al. · European Journal of Pharmacology · 2009 · 30 citations

Pancreatic β-Cells, Metabolic Syndrome, α-Glucosidase Inhibitor Miglitol +11

The α-glucosidase inhibitor miglitol suppresses postprandial hyperglycaemia and interleukin-1β and tumour necrosis factor-α gene expression in rat peripheral leucocytes induced by intermittent sucrose loading

Yutaro Tanaka, Kazuki Mochizuki, Nanae Fukaya et al. · British Journal Of Nutrition · 2009 · 23 citations

Treatment with the α-glucosidase inhibitor miglitol from the preonset stage in Otsuka Long-Evans Tokushima Fatty rats improves glycemic control and reduces the expression of inflammatory cytokine genes in peripheral leukocytes

Kazuki Mochizuki, Nanae Fukaya, Yutaro Tanaka et al. · Metabolism · 2011 · 11 citations

Inflammation, Metabolic Syndrome, Anti-inflammatory +10